# Multiply Labs

> Robotic manufacturing systems for cell therapies, gene therapies, mRNA medicines and other complex biologics.

## Why it is interesting

Multiply addresses the manufacturing bottleneck that sits between AI-assisted drug discovery and patient delivery. Its commercial test is whether a small number of multimillion-dollar machines can become a repeatable platform with attractive hardware, consumables and service economics.

## Profile

- **Latest funding:** Series B — $75M (October 6, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $75M
- **Stage:** series-b
- **Status:** private
- **Industries:** ai-ml, healthtech, biotech-life-sciences, robotics, deep-tech
- **Coverage:** full
- **Last updated:** 2026-10-07
- **Latest funding investors:** NantWorks, AstraZeneca Ventures, Lingotto Innovation, Legend Biotech, Fifty Years, Ora Global, Teradyne Ventures, Strange Ventures, Casdin Capital, Lux Capital, Founders Fund

## Key facts

- October 2026: announced a $75M Series B led by NantWorks, bringing disclosed capital above $100M.
- Customers and strategic investors include AstraZeneca and Legend Biotech.
- Company says its installed base remains in the high single digits, highlighting both commercial validation and early scale.

## Funding history

- Series B · $75M · October 6, 2026
  Source: https://www.multiplylabs.com/news

## Investors in our directory

- https://venturecapitaltracker.com/fund/nantworks
- https://venturecapitaltracker.com/fund/astrazeneca-ventures
- https://venturecapitaltracker.com/fund/lingotto-innovation
- https://venturecapitaltracker.com/fund/fifty-years
- https://venturecapitaltracker.com/fund/teradyne-ventures
- https://venturecapitaltracker.com/fund/lux-capital
- https://venturecapitaltracker.com/fund/founders-fund

## Related articles

- https://venturecapitaltracker.com/2026-multiply-labs-75m-series-b-drug-manufacturing

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 7, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/multiply-labs